Our client, a premier global biopharmaceutical organization, is seeking an Associate Director of Medical Communications & Publications (Solid Tumors). In this pivotal role, you will drive the strategy and execution of high-quality scientific publications and medical communication activities for assigned solid tumor assets.

A high-growth global specialty pharmaceutical organization is seeking a visionary Senior Medical Director to spearhead early-phase clinical development. Unlike a traditional "Big Pharma" environment, this role offers a pioneering opportunity to influence global strategy within an agile project leadership team. You will lead the transition of innovative therapeutics from early discovery through proof-of-concept for hematological malignancies and rare diseases.

The Program Manager operates under the matrix leadership of a Program Management Lead or functions independently as a lead for specific drug development programs. This role is assigned at the asset or indication level to deliver integrated cross-functional planning and oversee the execution of project sub-teams.

Our client is a pioneering, clinical-stage biopharmaceutical company dedicated to developing first-in-class targeted therapies for patients with significant unmet needs. Their lead program is a novel, small-molecule epigenetic inhibitor currently in clinical development for multiple myeloma and other hematologic and solid tumor malignancies.